Chengdu Kanghua Biological Products
VC Fund
Chengdu, China
Chengdu Kanghua Biological Products is a VC fund in Chengdu focused on Biotechnology and Genetics. Kanghua Biological is a research and development, production, and operation of preventive biological products.The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 groupMeningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department.It was founded in 2004 in Chengdu, Sichuan, China.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chengdu Kanghua Biological Products invests in
Stages Chengdu Kanghua Biological Products invests in
Countries Chengdu Kanghua Biological Products invests in
Investment Focus
Industry
- Biotechnology 3 (100%)
- Genetics 2 (67%)
- AgTech 1 (33%)
- Fitness 1 (33%)
- Wellness 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system | $41.2M / Series B / Aug 28, 2023 | ||
| Igenesis is a biotechnology company that provides molecular diagnostic technologies. | $15.8M / Series C / Mar 08, 2022 | ||
| Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases. | $22.7M / Series A / Nov 05, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chengdu Kanghua Biological Products invest in?
Chengdu Kanghua Biological Products invests primarily in Biotechnology, Genetics and AgTech startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chengdu Kanghua Biological Products last invest?
The most recent investment recorded for Chengdu Kanghua Biological Products closed in Aug 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
